GlassScriptPhysician profile
Jorge S Szauer
NPI 1972809879
$546.65
in general payments reported to CMS, 2019-2025
14 companies · $96.59 in 2025
The $96.59 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
See the full distribution for Undersea and Hyperbaric Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $58.28 · 2021: $114 · 2022: $115 · 2024: $32.58 · 2025: $96.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $89.56 | 2019 | |
| Abbvie INC. | $57.79 | 2021-2022 | |
| Kerecis Limited | $54.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Seagen INC. | $54.21 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $46.81 | 2020 | |
| Innocoll Pharmaceuticals Limited | $43.44 | 2021 | |
| Polynovo North America LLC | $42.23 | 2025 | Novosorb Btm |
| Biotissue Holdings INC. | $32.58 | 2024 | |
| Kci USA, INC. | $29.85 | 2020-2021 | |
| Smith+Nephew, INC. | $27.49 | 2019 | |
| Eisai INC. | $24.56 | 2022 | |
| Checkpoint Surgical, INC | $19.36 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $12.83 | 2019 | |
| Misonix INC | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Szauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.